Gateway to Hope 2019

Gateway to Hope 2019

Learn about advancements in cancer clinical trials
funded by Gateway for Cancer Research.

Sunday, June 2nd, 2019
6:00 p.m. - 7:30 p.m.
5:30 p.m. Doors Open


The Ritz Carlton Chicago
160 East Pearson Street
at Water Tower Place
Chicago, IL 60611


Speakers

Join us to be among the first to learn details of this exciting new funding opportunity, including how to apply for this grant! The brief program will feature:

Dr. Maurie Markman – President of Medicine and Science, Cancer Treatment Centers of America 
Discussing the impact of the new scientific partnership between Conquer Cancer/ASCO and Gateway for Cancer Research.

Dr. Cynthia Wetmore – Division Chief, Center for Cancer and Blood Disorders at Phoenix Children’s Hospital and Current Gateway Grantee
Sharing her experience as a newly minted Gateway-funded researcher.


Announcing the Gateway Discovery Grant Program!

Gateway for Cancer Research is proud to launch a scientific partnership with Conquer Cancer, the ASCO Foundation, which establishes the new Gateway Discovery Grant Program. We will identify compelling areas of inquiry in early phase cancer research and fund the talented clinician-scientists best positioned to pursue them.


Transportation

Complimentary shuttle service is available from the McCormick Place to the area immediately
surrounding The Ritz-Carlton.

Take Route 6 – Gate 3 (South Building, Level 1, near Room S100),
which will drop you off at The Westin, a short walk from The Ritz-Carlton.

For more information about ASCO transportation options, visit https://meetings.asco.org/am/transportation-options.


Not an official event of the 2019 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO©, CancerLinQ©, or the Conquer Cancer© The ASCO Foundation. Not CME-accredited.

 
99 cents of every dollar received directly funds cancer clinical trials

58

Current Gateway-funded clinical trials

170+

Clinical trials funded at leading institutions worldwide

$16.56

Funds one patient for one day at a Gateway-funded clinical trial

 
 

Mission Partners